The Trust is holding its first Reseach Event on Monday, November 25. 9am - 3pm. It will be held at the Briar Court Hotel, Birchencliffe, Halifax Road.

To book a place email: researchevent@cht.nhs.uk. Lunch provided. Nursing, AHPs and Community are all welcome to attend.

Here's Asifa Ali our R&D lead explains more about it.

  • Why are we doing it? Our  Trust has been undertaking research for over 30 years and taken part in national and international studies that have changed clinical practice and treatment for patients in the NHS and globally? We engage with an eclectic mix of institutions such academia, pharmaceuticals, life sciences industry, charities and the medical research council to deliver research at CHFT. Our #BePartOf Research event in November will showcase the Trust's contribution to research and highlight the opportunities for CHFT to grow its research capability further. It will be an exciting day and we will hear from speakers to include the NIHR CEO Professor Jonathan Sheffield, industry partners and our CHFT research teams.  During the table top exercises there will be opportunity to discuss specific topics such as ‘getting started in research’ and ‘opportunities for staff’. This event is for all staff interested in research and we especially encourage our AHPs, community, ward and clinic nurses to come along and see how research could be something for them. 

 

  • Can you highlight the areas our trials cover? We have research taking place in numerous specialties such Cancer (breast, colorectal, gynaecological, haematology, lung, lymphoma, prostate, gastrointestinal), cardiovascular, diabetes, gastrointestinal, obstetric, infection, neurological, hepatology, paediatric, pathology, respiratory, renal, stroke, surgery & sexual health. 

 

  • What is the most exciting one the moment in terms of patients outcomes?  Many of our current trials are offering very sick patients access to trials where there is currently no treatment option left. This gives patients hope and potential health benefits should these trials show effective outcomes.